Novartis said its Chief Executive Joe Jimenez is to step down in January after leading the company through a tumultuous eight years marked by big patent expiries and intensifying scrutiny on drug pricing in the U.S.
from WSJ.com: US Business http://ift.tt/2vF9f1r
via IFTTT
No comments:
Post a Comment